Quick Answer
Lexaria Bioscience Corp. reported Gross Profit of $703.2 thousand for the year ending 2025.
- Lexaria Bioscience Corp. showed an increase of +53.1% in Gross Profit from 2024 to 2025.
- This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $128.3 thousand | Q2 2013: $88.3 thousand | Q3 2013: $76.2 thousand | Q1 2014: $33.4 thousand | Q1 2014: $0.00 | Q2 2014: $57.5 thousand | Q2 2014: $0.00 | Q3 2014: $53.8 thousand | Q4 2014: $0.00 | Q1 2015: $831.00 | Q2 2015: -$2.5 thousand | Q4 2015: -$3.6 thousand | Q1 2016: -$4.1 thousand | Q2 2016: -$3.1 thousand | Q4 2016: $8.3 thousand | Q1 2017: -$2.3 thousand | Q2 2017: $20.1 thousand | Q4 2017: $18.5 thousand | Q1 2018: $158.2 thousand | Q2 2018: $137.9 thousand | Q4 2018: $20.1 thousand | Q1 2019: $12.7 thousand | Q2 2019: $56.8 thousand | Q4 2019: $2.5 thousand | Q1 2020: -$20.6 thousand | Q2 2020: $16.1 thousand | Q4 2020: $231.2 thousand | Q1 2021: $161.4 thousand | Q2 2021: $144.1 thousand | Q4 2021: $8.3 thousand | Q1 2022: $24.3 thousand | Q2 2022: $81.1 thousand | Q4 2022: $81.9 thousand | Q1 2023: $17.1 thousand | Q2 2023: $117.6 thousand | Q2 2023: $65.0 thousand | Q4 2023: $146.5 thousand | Q1 2024: $145.0 thousand | Q2 2024: $84.0 thousand | Q4 2024: $181.2 thousand | Q1 2025: $174.0 thousand | Q2 2025: $174.0 thousand | Q4 2025: $0.00.
- Over the full 17 years of available data (2010 to 2025), Lexaria Bioscience Corp.'s Gross Profit has grown by 691.4%.
- Historical annual values: Fiscal year 2025: $703.2 thousand | Fiscal year 2024: $459.5 thousand | Fiscal year 2023: $194.7 thousand | Fiscal year 2023: $538.3 thousand | Fiscal year 2022: $183.6 thousand | Fiscal year 2021: $547.4 thousand | Fiscal year 2020: $215.4 thousand | Fiscal year 2019: $199.7 thousand | Fiscal year 2018: $408.1 thousand | Fiscal year 2017: $33.9 thousand | Fiscal year 2016: -$4.9 thousand | Fiscal year 2015: -$15.2 thousand | Fiscal year 2014: $0.00 | Fiscal year 2013: $302.3 thousand | Fiscal year 2012: $574.5 thousand | Fiscal year 2011: $465.9 thousand | Fiscal year 2010: $88.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: